Business / Finance

RSS

Vitamix Laboratories opens new manufacturing facility in Commack, New York

Vitamix Laboratories, one of the most highly regarded vitamin manufacturers in the industry, recently announced a major milestone: the company has moved into a new 23,175 square foot state-of-the-art manufacturing facility in Commack, New York.

31 May 2014

VMGI enters into MOU with Power Shark Capital for distribution of beauty and cosmetic products

Verde Media Group Inc. (OTC: VMGI) is pleased to announce that it has recently entered into a Memorandum of Understanding, through its subsidiary Beautyject Inc., with Power Shark Capital ("PSC") for the sale and distribution of its beauty and cosmetic products throughout North America.

31 May 2014

Agena Bioscience acquires Sequenom’s Bioscience business

Agena Bioscience, Inc., a portfolio company of Telegraph Hill Partners (THP), today acquired the Bioscience business of Sequenom, Inc., which sells the MassARRAY® System for mass spectrometry-based detection of nucleic acids in research and clinical laboratories.

31 May 2014

PGFX Patent Holdings acquires proprietary methods, devices, intellectual property from Orogen Biosciences

On Friday, April 18th PGFX Patent Holdings, operating as Heritage Biosciences, LLC made an asset acquisition of proprietary methods, devices and intellectual property from Orogen Biosciences, Inc.

31 May 2014

AEA Investors, Fitness Capital Partners, and Ontario Teachers’ Pension Plan acquire 24 Hour Fitness

24 Hour Fitness USA, Inc. announced that AEA Investors, a leader in the private equity industry; Ontario Teachers' Pension Plan, Canada's largest single-profession pension plan - and one of the world's largest; and Fitness Capital Partners, a fund organized by Dean Bradley Osborne and Global Leisure Partners have completed their acquisition of the Company from Forstmann Little & Co.

31 May 2014

Inovio Pharmaceuticals’ reverse stock split to become effective on June 5, 2014

Inovio Pharmaceuticals, Inc. today announced that its previously announced 1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.

30 May 2014

Echo Therapeutics proposes to file investor presentation with SEC

Echo Therapeutics, Inc. (NASDAQ: ECTE), a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it is filing an investor presentation with the U.S. Securities and Exchange Commission (SEC) that comments on, among other things, the pending proxy contest by a dissident stockholder group led by Platinum Management (NY) LLC.

30 May 2014

TPP wins $500,000 grant from Biogen Idec to help students start and run own businesses

The Biogen Idec Foundation has awarded a $500,000 grant to The Possible Project (TPP), a non-profit organization that teaches high school students how to start and run their own businesses through a tailored curriculum, and access to technology and to mentors from the local business community.

29 May 2014

AMSURG acquires Sheridan Healthcare in cash and stock transaction valued at $2.35 billion

AMSURG Corp. and Sheridan Healthcare, a portfolio company of Hellman & Friedman, LLC, today announced that their respective Boards of Directors have unanimously approved a definitive agreement under which AMSURG will acquire Sheridan Healthcare in a cash and stock transaction valued at approximately $2.35 billion.

29 May 2014

Transgenomic signs license with Dana-Farber to develop multiplexed ICE COLD-PCR technology

Transgenomic, Inc., a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it has signed a license with the Dana-Farber Cancer Institute for worldwide rights to develop and commercialize multiplexed versions of its ICE COLD-PCRTM technology (MX ICE COLD-PCR).

28 May 2014

National Surgical Hospitals purchases interest in The Fairfield Surgery Center

National Surgical Hospitals, Inc., an owner, operator and developer of surgery centers and surgical hospitals in partnership with local physicians, today announced that it has purchased an interest in The Fairfield Surgery Center, LLC located in Fairfield, Connecticut.

28 May 2014

PCI | HealthDev adds Greg Pakes as Controller

PCI | HealthDev™ formerly Physicians' Capital Investments® (the Company), a leader in medical real estate development and medical investment solutions, is pleased to announce the addition of Greg Pakes as Controller.

28 May 2014

MRA announces acquisition of TrustHCS's cancer registry services division

Medical Record Associates, LLC, (MRA) announces the acquisition of TrustHCS's cancer registry services division. The acquisition of TrustHCS's cancer registry business compliments and expands MRA's existing cancer registry service offerings which assist healthcare customers in maintaining registry compliance, staffing registry programs and preparing for ACoS surveys.

28 May 2014

FDA postpones Dispute Resolution Panel for FzioMed’s Oxiplex PMA

FzioMed, Inc. today announced it has agreed with the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) to postpone the Dispute Resolution Panel for its Oxiplex PMA; the meeting was previously scheduled for June 10.z

28 May 2014

Trimel announces top-line results of Phase II clinical trial evaluating efficacy of Tefina

Trimel Pharmaceuticals Corporation (TSX: TRL) announced today top-line results of its Phase II clinical trial evaluating the efficacy and safety of Tefina™, a "use-as-required" testosterone nasal gel for the treatment of Female Orgasmic Disorder (FOD).

28 May 2014

Spokane Valley Cancer Center partners with SCCA Network to become 12th Member in Northwest

Spokane Valley Cancer Center joined the Seattle Cancer Care Alliance (SCCA) Network to become its 12th Member in the Northwest this month. This relationship will expand access to cancer treatment options and help foster advances in cancer care in the greater Spokane community.

28 May 2014

Business / Finance

Vitamix Laboratories opens new manufacturing facility in Commack, New York

VMGI enters into MOU with Power Shark Capital for distribution of beauty and cosmetic products

Agena Bioscience acquires Sequenom’s Bioscience business

PGFX Patent Holdings acquires proprietary methods, devices, intellectual property from Orogen Biosciences

AEA Investors, Fitness Capital Partners, and Ontario Teachers’ Pension Plan acquire 24 Hour Fitness

Inovio Pharmaceuticals’ reverse stock split to become effective on June 5, 2014

Echo Therapeutics proposes to file investor presentation with SEC

TPP wins $500,000 grant from Biogen Idec to help students start and run own businesses

AMSURG acquires Sheridan Healthcare in cash and stock transaction valued at $2.35 billion

Transgenomic signs license with Dana-Farber to develop multiplexed ICE COLD-PCR technology

National Surgical Hospitals purchases interest in The Fairfield Surgery Center

PCI | HealthDev adds Greg Pakes as Controller

MRA announces acquisition of TrustHCS's cancer registry services division

FDA postpones Dispute Resolution Panel for FzioMed’s Oxiplex PMA

Trimel announces top-line results of Phase II clinical trial evaluating efficacy of Tefina

Spokane Valley Cancer Center partners with SCCA Network to become 12th Member in Northwest

Twist Bioscience raises $26M in Series B financing, receives $5.1M DARPA contract

Alligator Bioscience acquires rights to drug development candidate ADC-1013

Abiogen Pharma, Lee's Pharma sign deal to market Neridronic Acid

Inovio Pharmaceuticals proposes 1-for-4 reverse split of common stock

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News